
Leaders of the newly launched Psychedelic Pharmacist Foundation discuss pharmacists' critical role in psychedelic-assisted therapy and patient education.

Leaders of the newly launched Psychedelic Pharmacist Foundation discuss pharmacists' critical role in psychedelic-assisted therapy and patient education.

Three psychiatric pharmacists highlight trends in psychiatric pharmacotherapy that were shared at the AAPP 2026 Annual Meeting.

Marilyn Bulloch, PharmD, discusses the persistent burden of hepatitis B, evolving adult vaccination recommendations, and how pharmacists can improve vaccine uptake through accessible, stigma-free patient counseling.

On Chen, MD; and Tahmid Rahman, MD, join Pharmacy Focus to discuss the world's first commercial administration of plozasiran at Stony Brook Medicine.

Headache specialist Shivang Joshi, MD, MPH, RPh, FAHS, explains how the dual-mechanism combination of meloxicam and rizatriptan fits into acute migraine treatment.

William Van Decker, MD, discusses the key priorities of the upcoming ACC Legislative Conference, including telehealth, cardiovascular rehab, prior authorization reform, and the role of pharmacists in shaping patient-centered cardiovascular policy.

Jennifer Griffin, PharmD, MS, discusses the critical role of pharmacists in patient inhaler counseling, from when an inhaler is first prescribed to patient follow-up.

Gustavo Alva, MD, a board-certified psychiatrist, discusses the importance of mental health awareness among pharmacists and patients.

Derek Webb, PharmD, a community pharmacist and Virginia Board of Pharmacy member, provides comprehensive guidance on managing seasonal allergies, distinguishing between symptoms, and exploring treatment options for patients.

Experts discuss Project Lifeline’s integration of SBIRT in community pharmacies, highlighting its effectiveness in identifying and addressing opioid use disorder while exploring strategies for broader implementation.

In this episode, Jill Simonian and Codi Peterson explore the evolving role of pharmacists in medical cannabis, addressing legal complexities, patient counseling, and key considerations for safe and effective use.

Donna Ryan, MD discusses GLP-1 medications and new developments on the horizon, while providing some best practices for patients initiating treatment, including important nutritional and lifestyle changes,

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

Olivia Kinney, a national pharmacy practice manager at Kroger, discusses strategies for pharmacists to effectively address vaccine hesitancy by building trust with patients.

Jeffrey Goad discusses key considerations for travelers regarding medications, maintaining medication schedules across time zones, ensuring proper vaccinations, and the importance of consulting health care professionals before international trips.


Molly McGraw, PharmD, BCPS, manager of clinical pharmacy at UPMC Health Plan and Kim Castelnovo, RPh, Pharmacy Manager at Community Care Behavioral Health Organization, talk about the importance of mental health care for patients.

On this episode, Amie Stephens, Emilee Kennelly, and Max Baire, discuss social determinants of health and how they can impact patient outcomes and medication adherence.

Cristin Hackel discusses the current state of OTC contraception options, the differences between OTC and prescription methods, and how pharmacists can promote education and awareness.

This podcast episode discussed the impact of celebrity endorsements on trends in weight loss drugs like Ozempic, body image issues, and the role of pharmacists in educating patients on appropriate use of GLP-1 medications for weight management and chronic diseases.

This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.

The podcast highlights addressing misinformation, the impact of celebrity endorsements in pharmaceuticals, and the important role of pharmacists in educating patients.

This episode highlights strategies for pharmacists and pharmacies to address social determinants of health barriers through leveraging PQA's SDOH Resource Guide.

Anaïs Webster Mennuti, PharmD and Kristin Speer, PharmD, BCPS, discuss their new documentary that highlights the understaffed and overwhelmed reality of retail pharmacy.

Tune in to this episode of Pharmacy Focus for a deep dive into the world of independent pharmacists prescribing, featuring insights and expertise from Deeb Eid.

On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars.

Tune in to this episode of Pharmacy Focus to gain a deeper understanding of the AAPT Fall Seminar, the evolving landscape of pharmacy practice, and the crucial roles played by pharmacy technicians.

Harsha Rajasimha, PhD, MS, founder and CEO of Jeeva Informatics Solutions, discusses the importance of representation of women and minority groups in clinical trials.

Tom Knight, founder and CEO of Invistics, now part of Wolters Kluwer, discusses the dangers of drug diversion and how this could negatively impact affect patients.

Nikhil Palekar discusses the FDA approval of lecanemab-irmb (Leqembi, Eisai) and what this means for those who have Alzheimer Disease.